Zocor added to WellPoint GenericSelect Program
Eligible members in these markets can receive up to four months of medication for free as an incentive to switch to simvastatin from brand-name statins.
WellPoint NextRx will include simvastatin, the generic equivalent of Merck's cholesterol drug Zocor, to the list of drugs included in WellPoint's GenericSelect program in seven additional states: Connecticut, Indiana, Kentucky, Maine, New Hampshire, Ohio, and Virginia. Through GenericSelect, eligible members in these markets can receive up to four months of medication for free as an incentive to switch to simvastatin from brand-name statins. GenericSelect is designed to provide improved access to affordable generics used to treat high cholesterol, high blood pressure, diabetes, arthritis pain, and depression. The drugs on the GenericSelect list are among the most commonly prescribed medications for these conditions. Simvastatin will be available to WellPoint members in these new markets by the end of March. WellPoint NextRx is a wholly owned PBM division of Indianapolis-based WellPoint Inc.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
